Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Philadelphia › NPI 1124023015
Hospital

Nazareth Hospital

Nazareth Hospital was paid $28.16M by Medicaid between Jan 2019 and Dec 2024, across 177 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.

33Billing provider infoNAZARETH HOSPITAL
PHILADELPHIA, PA 19152
33aNPI1124023015assigned 06/16/2005
28Total paid$28.16M
24GClaims318,353
24DCodes billed177
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#7 of 154
Median peer was paid$2.82M
This provider vs. median10.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019537$48K
202055,061$3.24M
202196,302$8.36M
202237,746$5.56M
202361,404$5.70M
2024incomplete67,303$5.25M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 31% 29,375 27,848 $8.82M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 23,205 22,491 $6.44M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 21% 18,212 17,131 $5.79M
G0378 Hospital observation service, per hour 12% 2,241 1,830 $3.52M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.5% 6,789 6,620 $1.83M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 166 163 $274K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive <1% 3,481 907 $264K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,948 3,781 $121K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,098 533 $117K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 270 156 $92K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 317 308 $80K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 318 307 $54K
165 more codes
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,436 $53K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 116 $43K
77067 Screening mammography, bilateral, including computer-aided detection <1% 342 $38K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,379 $38K
93975 <1% 733 $34K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 12,217 $33K
80053 Comprehensive metabolic panel <1% 18,361 $30K
73630 <1% 1,198 $24K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 222 $22K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 22,522 $21K
71045 Radiologic examination, chest; single view <1% 5,709 $20K
97161 <1% 362 $20K
71046 Radiologic examination, chest; 2 views <1% 1,779 $17K
70450 Computed tomography, head or brain; without contrast material <1% 1,505 $16K
93970 <1% 166 $15K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 544 $15K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 102 $15K
76641 <1% 178 $14K
76830 Ultrasound, transvaginal <1% 436 $13K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 323 $12K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 156 $12K
84484 <1% 7,049 $11K
96375 Therapeutic injection; each additional sequential IV push <1% 4,166 $11K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 396 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 327 $10K
72100 <1% 296 $9K
0012A <1% 131 $9K
71275 Computed tomographic angiography, chest, with contrast material <1% 386 $9K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,189 $9K
93971 <1% 238 $9K
0011A <1% 170 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 311 $8K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 362 $8K
93017 <1% 104 $7K
73610 <1% 482 $7K
36415 Collection of venous blood by venipuncture <1% 14,504 $6K
77066 Tomosynthesis, mammo <1% 42 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,531 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 744 $6K
80048 Basic metabolic panel (calcium, ionized) <1% 3,403 $6K
76801 <1% 404 $5K
93041 <1% 7,614 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 189 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 312 $5K
73564 <1% 402 $4K
83690 <1% 6,072 $4K
73030 <1% 305 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 279 $3K
83880 <1% 999 $3K
73130 <1% 468 $3K
83735 <1% 3,956 $3K
85730 <1% 2,938 $3K
73502 <1% 99 $3K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 12 $3K
85610 <1% 3,239 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 324 $2K
84443 Thyroid stimulating hormone (TSH) <1% 689 $2K
76770 <1% 37 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $2K
81001 <1% 7,023 $2K
84703 <1% 1,994 $2K
72070 <1% 43 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 66 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,287 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,868 $2K
96361 Intravenous infusion, hydration; each additional hour <1% 146 $2K
90715 <1% 407 $2K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,381 $2K
74018 <1% 40 $1K
72040 <1% 28 $1K
70486 <1% 72 $1K
73110 <1% 154 $1K
84702 <1% 656 $1K
85027 <1% 1,009 $1K
71250 <1% 42 $1K
93350 <1% 12 $1K
80061 Lipid panel <1% 192 $1K
80177 <1% 78 $954.50
84100 <1% 1,757 $899.54
C1769 Guide wire <1% 28 $873.61
86900 <1% 632 $836.25
81003 <1% 2,740 $808.66
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $749.08
81025 <1% 5,385 $722.81
86850 <1% 418 $674.83
87186 <1% 430 $602.70
80076 <1% 358 $574.19
88342 <1% 65 $554.76
85007 <1% 852 $543.19
87077 <1% 480 $512.50
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 29 $495.31
87081 <1% 778 $493.14
86901 <1% 626 $485.46
J7030 Infusion, normal saline solution , 1000 cc <1% 6,514 $481.45
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 835 $478.77
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 835 $478.23
85379 <1% 714 $471.17
83605 <1% 619 $464.79
83036 Hemoglobin; glycosylated (A1C) <1% 222 $462.59
97165 <1% 24 $445.30
87040 <1% 319 $444.48
82803 <1% 153 $393.88
0352U <1% 91 $387.90
82550 <1% 405 $384.01
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 198 $351.86
87641 <1% 13 $341.55
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 366 $314.16
J1245 Injection, dipyridamole, per 10 mg <1% 32 $264.81
76870 <1% 13 $227.43
J1644 Injection, heparin sodium, per 1000 units <1% 500 $207.39
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 343 $202.47
J2704 Injection, propofol, 10 mg <1% 1,222 $198.94
93976 <1% 48 $174.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 431 $173.65
J0690 Injection, cefazolin sodium, 500 mg <1% 153 $166.41
J1170 Injection, hydromorphone, up to 4 mg <1% 442 $158.64
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 13 $154.72
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,804 $144.37
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 12 $142.18
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 742 $141.17
73590 <1% 18 $131.06
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 984 $123.12
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,033 $122.73
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,004 $121.49
87210 <1% 308 $113.49
80320 <1% 17 $111.13
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 13 $97.34
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,298 $91.29
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,250 $89.21
82607 <1% 12 $89.18
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,118 $84.06
82746 <1% 12 $82.32
12001 <1% 25 $71.06
87430 <1% 219 $69.30
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 972 $59.18
73080 <1% 30 $57.04
97116 <1% 71 $51.77
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 53 $28.34
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,009 $26.47
J1650 Injection, enoxaparin sodium, 10 mg <1% 750 $24.70
88304 <1% 14 $18.86
J3370 Injection, vancomycin hcl, 500 mg <1% 27 $16.62
J7120 Ringers lactate infusion, up to 1000 cc <1% 468 $16.22
82150 <1% 57 $15.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 143 $10.37
J2060 Injection, lorazepam, 2 mg <1% 519 $9.17
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,002 $9.08
A9270 Non-covered item or service <1% 12,420 $7.74
J0780 Injection, prochlorperazine, up to 10 mg <1% 62 $7.65
J7050 Infusion, normal saline solution, 250 cc <1% 679 $5.88
87147 <1% 12 $5.26
82010 <1% 14 $5.00
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 14 $3.67
86140 <1% 15 $3.55
J1815 Injection, insulin, per 5 units 0% 485 $0.00
96376 0% 97 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 12 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 294 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 44 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 15 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 129 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 36 $0.00
97530 Therapeutic activities, direct patient contact, each 15 minutes 0% 33 $0.00
84439 0% 14 $0.00
87420 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWAJDA, DAVID (CHIEF FINANCIAL OFFICER, VP FINANCE)